1. Introduction

Animal biotechnology and livestock genetic improvement are important components of Morocco's agricultural development, food security, veterinary health protection and rural economic growth. These technologies involve scientific methods used to improve the genetic characteristics, productivity, disease resistance and reproductive capacity of livestock.

Morocco has traditionally relied on selective breeding, crossbreeding, artificial insemination and the conservation of indigenous animal breeds. More recently, developments in reproductive biotechnology, molecular genetics, genomic selection and genetic analysis have created new regulatory challenges.

Animal biotechnology may involve:

Artificial insemination and semen preservation.

Embryo transfer and reproductive biotechnology.

Genetic selection of cattle, sheep, goats and camels.

Genomic testing and DNA-based livestock identification.

Gene editing and genetic modification of animals.

Disease-resistant livestock development.

Preservation of indigenous animal genetic resources.

Biotechnology-assisted livestock productivity improvement.

The Moroccan regulatory framework does not consist of one comprehensive statute specifically governing all animal biotechnology. Instead, several agricultural, veterinary, environmental, food-safety and international legal instruments regulate different aspects of these activities.

The principal regulatory institution is the National Office for Food Safety (ONSSA).

2. Constitutional and Legal Foundations

The Moroccan Constitution of 2011 provides the broader institutional and environmental foundation for regulating agricultural biotechnology.

Relevant constitutional principles include:

Protection of public health.

Environmental protection and sustainable development.

Legality and accountability of public administration.

Protection of economic and agricultural interests.

Access to scientific and technological development.

These principles support governmental regulation of biotechnology where genetic interventions may affect animal health, biodiversity, food safety or the environment.

The regulatory objective is to balance three competing interests:

First, encouraging scientific innovation and livestock productivity.

Second, protecting animal health, genetic diversity and environmental sustainability.

Third, protecting consumers and agricultural producers against unsafe or misleading biotechnology practices.

3. National Office for Food Safety (ONSSA)

Principal regulatory authority

The National Office for Food Safety was established under Law No. 25-08, promulgated by Dahir No. 1-09-20 of 18 February 2009.

ONSSA is responsible for several activities directly relevant to livestock biotechnology.

Its functions include:

Monitoring animal diseases.

Supervising veterinary health requirements.

Controlling animal feed and animal products.

Monitoring veterinary medicinal products.

Authorizing or registering livestock establishments.

Controlling animal and animal-product imports.

Conducting health-risk assessments.

Supervising relevant sanitary certification procedures.

The legislation gives ONSSA an important role in preventing unsafe biological materials, animal products and veterinary practices from entering the agricultural production chain.

onssa.gov.ma+1

Legal significance

Suppose a Moroccan livestock company imports genetically selected cattle embryos from another country.

The company cannot treat the embryos simply as ordinary commercial goods. Their importation raises veterinary sanitary requirements, documentation, disease-control and border-inspection questions.

ONSSA's authority is therefore particularly important in regulating the movement of reproductive biological materials.

4. Law No. 24-89: Importation of Animal Reproductive Materials

One of the most important statutes for animal reproductive biotechnology is Law No. 24-89, promulgated by Dahir No. 1-89-230 of 10 September 1993.

This legislation establishes veterinary sanitary measures concerning the importation of:

Animals.

Animal foodstuffs.

Products of animal origin.

Animal propagation materials.

Certain aquatic products.

Importantly, Article 1 expressly includes the following within the concept of animal propagation materials:

Frozen sperm.

Fresh embryos.

Frozen embryos.

Other biological products intended for animal reproduction.

These provisions are particularly relevant to artificial insemination, embryo transfer and international livestock breeding programmes.

onssa.gov.ma

Practical example

A Moroccan agricultural enterprise wishes to import frozen bovine embryos containing genetic material from a high-productivity dairy breed.

The importation is subject to the veterinary inspection framework under Law No. 24-89.

The regulatory concern is not merely whether the embryo possesses desirable genetic characteristics. Authorities must also consider its sanitary status and compliance with applicable import requirements.

Legal importance: Law No. 24-89 provides a direct legal foundation for controlling international movement of animal reproductive biotechnology materials.

5. Law No. 1-75-292: Protection Against Contagious Animal Diseases

Dahir No. 1-75-292 of 19 September 1977 establishes measures for protecting domestic animals against contagious diseases.

The framework provides for:

Veterinary inspection.

Reporting suspected contagious diseases.

Isolation and quarantine measures.

Identification and control of infected animals.

Destruction of infected animals where legally required.

Sanitary supervision of livestock establishments.

Its provisions were amended by Law No. 61-22, promulgated in 2023 and published in Official Bulletin No. 7262 on 4 January 2024.

ONSSA+1

Application to animal biotechnology

Genetic improvement programmes can increase livestock productivity, but they must not undermine disease-control requirements.

For example, breeding programmes involving imported animals should incorporate disease-screening and veterinary supervision.

Similarly, the introduction of genetically selected animals into an existing herd must not become a mechanism for spreading contagious diseases.

The legislation consequently provides an important veterinary-health safeguard for biotechnology-assisted livestock development.

6. Law No. 28-07: Food Safety and Genetically Improved Livestock

Law No. 28-07 of 11 February 2010 concerns the sanitary safety of food products.

It establishes requirements intended to ensure that food products and animal feed do not create unacceptable risks to human or animal health.

Decree No. 2-10-473 of 6 September 2011 provides for the implementation of certain provisions of this legislation.

The framework is relevant to:

Meat from genetically improved animals.

Milk and dairy products.

Animal feed containing biological materials.

Veterinary drug residues.

Food contamination.

Processing and marketing of animal products.

The law also establishes restrictions on importing, marketing or exporting dangerous animal-feed products.

ONSSA+1

Example

A livestock producer develops cattle with enhanced milk productivity through conventional genetic selection.

The genetic improvement itself does not automatically make the resulting milk unsafe or unlawful.

However, the milk must comply with applicable food-safety standards, including sanitary requirements and relevant controls concerning veterinary medicines and contaminants.

This distinction is essential: genetic productivity and food safety are separate regulatory questions.

7. Regulation of Genetic Improvement and Indigenous Livestock Breeds

Morocco has important indigenous livestock genetic resources, including local sheep and goat breeds adapted to different climatic and ecological conditions.

Genetic improvement programmes must therefore balance productivity enhancement with conservation of indigenous genetic characteristics.

A significant instrument is Decree No. 2-13-325 of 20 May 2014, which regulates state incentives for intensifying animal production.

The decree provides for financial assistance, subsidies and technical support in areas including:

Livestock nutrition.

Genetic improvement of animal species.

Construction of livestock buildings.

Livestock equipment.

Technical assistance to livestock breeders.

The decree was also the subject of a proposed amendment, Decree No. 2.23.723, approved by the Government Council in March 2024. The announced objective included protecting local breeds and identifying geographical areas associated with their preservation. Government approval of the draft should not, by itself, be confused with proof of its final promulgation.

QanounAI+2

Legal significance

The government recognises that genetic improvement should not simply replace local breeds with commercially productive foreign breeds.

Instead, genetic improvement policies should consider:

Genetic diversity.

Climate adaptation.

Disease resistance.

Local agricultural traditions.

Long-term sustainability.

Preservation of valuable indigenous characteristics.

8. Artificial Insemination and Embryo Transfer

Artificial insemination and embryo transfer are among the most established applications of animal reproductive biotechnology.

Artificial insemination involves introducing selected semen into a female animal's reproductive system without natural mating.

Embryo transfer involves transferring an embryo produced through reproductive techniques into a recipient animal.

These technologies can help:

Increase the number of offspring from genetically superior animals.

Improve dairy and meat production.

Preserve valuable animal breeds.

Accelerate genetic improvement.

Facilitate international livestock breeding.

In Morocco, their legal treatment is connected to veterinary professional regulation, animal-health legislation, import controls and the regulatory framework administered by ONSSA.

Law No. 21-80 concerning the private practice of veterinary medicine, surgery and pharmacy is also relevant to veterinary professional responsibilities.

onssa.gov.ma+1

Important legal issue:

If an embryo transfer causes infection, reproductive injury or other harm, questions may arise concerning:

Veterinary negligence.

Professional standards.

Inadequate sanitary precautions.

Contractual liability.

Causation and compensation.

The precise liability depends on the circumstances and the applicable Moroccan civil and professional rules.

9. Genetic Modification and Gene Editing of Livestock

Modern biotechnology increasingly permits direct alteration of genetic material.

Examples include:

CRISPR-Cas gene editing.

Genetic modification for disease resistance.

Modification of growth characteristics.

Alteration of reproductive traits.

Genetic interventions affecting meat or milk production.

However, Morocco's biosafety framework requires particular attention.

Morocco ratified the Cartagena Protocol on Biosafety on 25 April 2011, and it entered into force for Morocco on 24 July 2011.

The Protocol addresses the safe transfer, handling and use of living modified organisms that may adversely affect biological diversity, taking into account risks to human health.

ONSSA is designated as the competent national authority for relevant administrative functions, while the Department of Sustainable Development acts as the national focal point.

Morocco Biodiversity+1

The regulatory gap

Morocco's biodiversity authorities have reported that the country does not have a comprehensive dedicated law governing living modified organisms (LMOs).

The country's biosafety approach has included an Agriculture Department circular dated 11 August 1999 restricting the introduction of products derived from LMOs, together with indirect regulation through sanitary, environmental and agricultural legislation.

The national biodiversity authority also identifies Article 11 of Law No. 39-12 on organic agricultural and aquatic production as prohibiting LMOs and products obtained from them in organic production.

Biodiversité du Maroc+1

Consequently, conventional genetic selection and genetic engineering should not be treated as legally identical.

A conventional breeding programme may operate under established livestock and veterinary arrangements, whereas the deliberate creation or release of genetically modified livestock raises additional biosafety questions.

10. Animal Welfare and Ethical Considerations

Animal biotechnology also raises important ethical concerns.

Genetic improvement programmes may involve reproductive manipulation, repeated embryo collection, invasive procedures and the selection of animals based on particular physical characteristics.

The relevant regulatory concerns include:

Animal suffering: Genetic interventions should not expose animals to unnecessary pain or injury.

Reproductive health: Artificial insemination and embryo-transfer procedures should be conducted under appropriate veterinary supervision.

Genetic abnormalities: Selection programmes should avoid promoting inherited characteristics that cause serious animal suffering.

Biodiversity: Excessive reliance on a small number of breeding animals may reduce genetic diversity.

Environmental responsibility: Genetically modified animals may create ecological concerns if released or escaped into natural environments.

These issues must be considered alongside the general veterinary, environmental and international obligations applicable in Morocco.

11. Important Case Laws and Judicial Principles

An important qualification is necessary: I have not identified a reported Moroccan court judgment directly deciding the legality of genetically modified livestock, CRISPR-edited cattle or animal embryo-transfer programmes.

Accordingly, the following are comparative judicial authorities. They provide useful legal principles but are not binding Moroccan precedents.

Case 1: European Commission v Poland (Case C-165/08, 2009)

Court of Justice of the European Union

This case concerned restrictions imposed by Poland on the marketing and registration of certain genetically modified seed varieties.

The European Court of Justice examined the compatibility of national restrictions with applicable European Union legislation.

Legal principle:

National governments cannot introduce restrictions that conflict with harmonised regulatory obligations without an appropriate legal basis.

Relevance to Morocco:

The case illustrates the importance of ensuring that livestock biotechnology restrictions are supported by clear legal authority and consistent with applicable international commitments.

It is particularly relevant to the regulation of imported genetically modified animal reproductive materials.

Case 2: Monsanto SAS and Others v Ministre de l'Agriculture et de la Pêche (Case C-58/10, 2011)

Court of Justice of the European Union

This litigation concerned emergency measures relating to genetically modified maize.

The Court examined the conditions under which national authorities could adopt protective measures against genetically modified organisms.

Legal principle:

Precautionary measures must operate within the applicable statutory framework and satisfy the legal conditions governing protective action.

Relevance to Morocco:

This principle is relevant when Moroccan authorities consider restrictions on imported genetically modified livestock materials or biological products.

It highlights the importance of scientific assessment and legally justified precautionary measures.

Case 3: Monsanto Technology LLC v Cefetra BV (Case C-428/08, 2010)

Court of Justice of the European Union

This case concerned the protection of patented genetic material in soybean products imported into Europe.

The dispute addressed the extent to which patent protection applied when patented DNA was present in imported processed products.

Legal principle:

Patent protection relating to genetic material depends on the applicable patent-law conditions and the functional role of that material.

Relevance to Morocco:

The judgment provides useful comparative guidance for disputes involving:

Patented livestock genetic technologies.

Genetic testing methods.

Biotechnology licensing agreements.

Commercial exploitation of genetic material.

Case 4: European Commission v Poland (Case C-165/08, 2009)

This case is also relevant to the relationship between national agricultural restrictions and harmonised biotechnology rules.

Its significance is the need for regulatory consistency rather than arbitrary national restrictions.

For Morocco, this provides a comparative lesson when designing domestic biotechnology legislation while complying with international trade and biosafety obligations.

Case 5: European Commission v France (Case C-121/07, 2008)

Court of Justice of the European Union

This case concerned France's failure to fulfil its obligations under European biotechnology legislation relating to genetically modified organisms.

Legal principle:

Member States must implement and enforce applicable biotechnology legislation effectively.

Relevance to Morocco:

It demonstrates why a country needs a functioning regulatory system for genetically modified organisms, including administrative coordination, authorisation procedures and enforcement mechanisms.

These European cases concern agricultural biotechnology and GMOs rather than directly adjudicating livestock genetic engineering. Their principles are therefore comparative.

12. International Legal Framework

Morocco's regulation of animal biotechnology must also be understood within international law.

The Cartagena Protocol is particularly important because genetically modified animals may create environmental and biodiversity risks.

Morocco is a party to the Cartagena Protocol but is not listed as a party to the Nagoya–Kuala Lumpur Supplementary Protocol on Liability and Redress.

Biosafety Clearing-House+1

13. Regulatory Challenges in Morocco

Several challenges remain important for the future development of animal biotechnology.

A. Absence of comprehensive animal biotechnology legislation

Morocco has veterinary and agricultural legislation, but these instruments do not amount to a complete regulatory framework for every modern genetic technology.

B. Limited specific regulation of gene editing

The legal distinction between conventional breeding, gene editing and transgenic modification requires clearer statutory treatment.

C. Protection of indigenous genetic resources

Commercial breeding programmes may threaten indigenous genetic diversity if selection is focused exclusively on productivity.

D. Cross-border movement of genetic materials

International transfers of embryos, frozen semen and genetically modified biological materials require effective documentation and sanitary controls.

E. Genetic ownership and intellectual property

Disputes may arise over ownership of breeding databases, patented biotechnology, reproductive materials and licensed genetic technologies.

F. Veterinary accountability

The responsibilities of breeders, veterinarians, laboratories, reproductive biotechnology centres and commercial suppliers need clear allocation.

G. Scientific capacity

Effective regulation requires laboratories capable of genetic testing, disease detection and reliable biological risk assessment.

14. Recommendations for Legal Reform

Morocco could strengthen its regulatory framework through the following measures:

Enact comprehensive animal biotechnology and genetic engineering legislation.

Establish separate approval procedures for conventional breeding, gene editing and transgenic animal development.

Introduce mandatory genetic traceability for relevant commercial breeding programmes.

Establish independent scientific biosafety assessments.

Strengthen animal welfare standards for reproductive biotechnology.

Create a national livestock genetic-resource conservation register.

Improve veterinary supervision of artificial insemination and embryo-transfer centres.

Establish specific liability provisions for genetic defects and biotechnology-related animal harm.

Improve international cooperation concerning genetic material imports and exports.

Introduce clear procedures for public disclosure and monitoring of approved genetically modified animals.

15. Conclusion

The regulation of animal biotechnology and livestock genetic improvement in Morocco operates through a combination of veterinary, agricultural, environmental, food-safety and international legal frameworks.

Law No. 25-08 provides the institutional foundation for ONSSA. Law No. 24-89 regulates the importation of animal reproductive materials, including semen and embryos. Law No. 1-75-292 provides protection against contagious animal diseases, while Law No. 28-07 establishes important food-safety obligations.

Decree No. 2-13-325 supports livestock genetic improvement through agricultural incentives and technical assistance.

The Cartagena Protocol provides an additional international framework for biosafety, although Morocco still faces challenges arising from the absence of comprehensive domestic legislation specifically regulating living modified organisms.

Ultimately, the future of animal biotechnology regulation in Morocco depends on establishing a balance between agricultural innovation, animal welfare, genetic-resource conservation, food safety and environmental protection.

16. Important Legal References and Research Sources

The following sources are particularly useful for further academic research:

Law No. 25-08 – Establishment of ONSSA.

Law No. 24-89 – Veterinary sanitary measures for imported animals and reproductive materials.

Law No. 61-22 – Amendment of animal disease legislation.

Law No. 28-07 – Food safety legislation.

Decree No. 2-13-325 – State incentives for animal production.

Morocco's implementation of the Cartagena Protocol.

Moroccan biodiversity and biosafety legislative framework.

ANOC – Genetic improvement programmes and reproductive biotechnology in Morocco.

Overall legal observation: Morocco has an established regulatory framework for conventional livestock genetic improvement, veterinary reproductive materials and animal-health protection. The legal position becomes more complicated when genetic engineering, gene editing and the environmental release of genetically modified animals are involved. The distinction between these activities is central to future Moroccan biotechnology legislation.